Racial differences exist in analgesic prescribing for children during emergency department and ambulatory surgery visits in the United States; however, it is unknown whether this is true in the outpatient setting. We examined racial and ethnic differences in outpatient analgesic prescribing using nationally representative data from 113,929 children from the Medical Expenditure Panel Survey. We also examined whether patient-provider race and ethnic concordance was associated with opioid prescription. White children were more commonly prescribed opioids as compared to minorities (3.0% vs 0.9%-1.7%), except for Native American children who had similar rates of opioid prescription (2.6%) as white children. Minorities were more likely to receive nonopioid analgesics than white children (2.0%-5.7% vs 1.3%). Although most white children had race-concordant providers (93.5%), only 34.3% of black children and 42.7% of Hispanic children had race-concordant providers. Among black children, having a race concordant usual source of care provider was associated with a decreased likelihood of receiving an opioid prescription as compared to having a white usual source of care provider (adjusted odds ratio [95% confidence interval] 5 0.51 [0.30-0.87]). For all other racial groups, patient-provider race-concordance was not associated with likelihood of opioid prescription. Racial differences exist in analgesic prescriptions to children at outpatient health care visits in the United States, with white children more likely to receive opioids and minorities more likely to receive nonopioid analgesics. Health care providers' race and ethnicity may play a significant role in extant analgesic differences. Further work should focus on understanding the role of provider race and ethnicity in analgesic differences to children in the United States.
Introduction
Racial and ethnic differences in pain management have been documented in children 0 to 17 years of age. 9 Previous studies have noted consistent racial discrepancies in opioid use during emergency department (ED) visits involving pain management where white, non-Hispanic children are consistently more likely to be administered opioids as compared to minority groups. 5, 22, 23 By contrast, data from ambulatory surgery settings are inconsistent, with some studies showing differences in opioid administration based on race, 16 and others showing no differences. 20 However, race and ethnic differences in opioid prescriptions to children have not yet been identified in outpatient health care settings, although this is a frequently occurring context for children to receive opioids. This is an important gap in knowledge that may inform the development and evaluation of interventions to reduce differences in pain management for children and adolescents, based on context of health care visits. 10 Minority individuals are often undertreated for pain relative to white individuals, 1 and recent evidence in adults show that health care providers' race may play a significant role in these observed disparities. 6, 11 Indeed, white health care providers often endorse the belief that white individuals are more pain sensitive than black individuals, which in turn affects their treatment of pain in minorities. 12, 26 Because 75% of the physician workforce in the United States is white, non-Hispanic, it stands to reason that differences in opioid prescription among children may be strongly associated with health care providers' race and ethnic status. However, there is no published literature on the association between health care providers' race and ethnic status and opioid prescription to children. This is also an important gap in knowledge that would significantly influence systemic interventions to address racial disparities in pain management among children in the United States.
Thus, the primary aim of this study is to examine differences in opioid prescription by child race in a representative sample of children in the United States receiving health care from outpatient health care providers. The context of outpatient settings is different from ED and surgery visits in that we expect providers and patients to be familiar with each other, thereby reducing some of the bias associated with treating unfamiliar patients. We hypothesized that no differences would be found in rates of opioid prescription between white children as compared to minority (black, Hispanic, and other racial groups) children. We also examined nonopioid analgesic prescription to children based on race and ethnicity. The secondary aim of this study was to examine associations between health care providers' race and ethnic status and differences in opioid prescribing for children.
This aim was accomplished in a subsample of 33% of participants who reported that their usual source of health care provider was a person (eg, MD, nurse practitioner, physician assistant, and other provider). Specifically, we hypothesized that children who have a race-concordant relationship with their usual source of health care provider would be more likely to receive opioid prescriptions as compared to children who were of different race/ ethnicity to their provider.
Methods

Survey design and population
This study involves secondary analyses of data from all children 0 to 17 years of age who participated in the 2003 to 2014 Medical Expenditure Panel Surveys (MEPS). The MEPS are a set of large-scale surveys of individuals, households, and their medical providers, including pharmacies, across the United States. Medical Expenditure Panel Survey is aimed at providing comprehensive estimates of health care use, including prescription medication use among the noninstitutionalized civilian population of the United States. Surveys are conducted by the National Centre for Health Statistics and the Agency for Healthcare Research and Quality. In-person interviews are conducted with parents of child participants during which sociodemographic information is gathered and all medical encounters, including prescribed medications, are documented. Data are then summarized to provide annual health care utilization for each child participant. Please see the MEPS web site http://meps.ahrq.gov/mepsweb/ for further information on design, sampling, and methodology. The sample used in our study includes all children 0 to 17 years of age who participated in the 2003 to 2014 MEPS. Approximately 8500 to 10,000 children participated in MEPS each year from 2003 to 2014, and our final sample included 113,929 children. For this study, we used a cross-sectional design to characterize the association between children's racial and ethnic category and analgesic prescribing, including both opioid and nonopioid analgesics.
Study variables
Race and ethnicity
The MEPS collects detailed information about self-reported race including whether participants identify as white, black, American Indian/Alaskan native, and Asian/Native Hawaiian/ Pacific Islanders. Ethnic data collected includes whether participants report being Hispanic vs non-Hispanic. We collapsed race and ethnic categories to create a variable containing 6 categories: white non-Hispanic, black nonHispanic, Hispanic, American Indian/Alaskan Native, Asian/ Native Hawaiian/Pacific Islander, and a category of children who reported multiple races. In this article, "white" refers to white, non-Hispanic individuals; "black" refers to black, non-Hispanic individuals; and "Hispanic" refers to white or black Hispanic individuals. We also refer to the Asian/Native Hawaiian/Pacific Islanders as "Asian" because Asian individuals formed the majority of this category. We were unable to further classify the Asian/Native Hawaiian/Pacific Islander category because of changes in the MEPS in year 2012. We excluded multiple race children from analysis (3.2% of participants). Our categorization of race and ethnicity is consistent with the 2010 United States census categorization.
Usual source of care provider
The MEPS collects data on whether each child participant has a particular doctor's office, clinic, health center, or other place that the child goes to if he/she is sick or needs advice about his/ her health (usual source of health care). In our sample, .90% of children had a usual source of health care. About 33% (n 5 35,707) of children's usual source of care was a specific health care provider (including MDs, nurses, nurse practitioners, physician assistants, and other providers). Participants reported the perceived race and ethnicity of their health care provider. We collapsed health care providers' race and ethnicity into 3 categories: white non-Hispanic, black non-Hispanic, and Hispanic. We did not include the other racial categories because of small sample sizes. To determine race-concordant relationships, we matched patients' and providers' race and ethnicity. Those assigned to the same race and ethnicity category were categorized as having a race-concordant relationship, whereas patients and providers whose race and ethnicity differed from each other were considered to not have a race-concordant relationship. Children who did not have a usual source of care provider listed several reasons, including seldom being sick (most common reason), recently moved to the area, do not know where to go, changed insurance plans, goes to different providers for different needs, and other reasons.
Sociodemographic and health status covariates
We extracted the following data for each child participant: age (categories: ,6 years, 6-11 years, and 12-17 years), sex (male/ female), geographic region (Northeast, Midwest, South, and West), and insurance coverage (private, public, or uninsured). Parents also reported on their child's physical and mental health status during the preceding year on a Likert-type scale with the following categories: excellent, very good, good, fair, or poor.
Health care use variables
To control for health care use, we extracted data on all outpatient health care visits and prescription medications used by child participants over the past year. Outpatient health care visits consisted of a sum of the number of office visits and hospital outpatient clinic visits made by participants over the past year. Office visits consisted of medical encounters, with both physicians and nonphysicians, that took place in office-based settings and clinics. Hospital outpatient visits consisted of medical encounters, with both physicians and nonphysicians, that took place in hospital-based outpatient clinic departments. The prescribed medications variable was a sum of the number of medications prescribed to children at all outpatient health care visits.
Identification and classification of analgesics
The MEPS collected data on medications prescribed to participants during the past year. Medical Expenditure Panel Survey surveyors then contacted participants' dispensing pharmacies and collected additional data about prescribed medications used, including Cerner's Multum Lexicon therapeutic class and medicine name. This included data on all medications associated with outpatient visits (eg, hospital outpatient clinic visits, office-based visits, and dental office visits); however, no information was collected on medications prescribed during hospital inpatient visits nor were data collected on over-the-counter (OTC) medications. We also excluded any opioids received by children after ED visits and hospital stays (both day and overnight stays) from analysis. We identified analgesic prescriptions using Cerner's Multum Lexicon therapeutic drug class classification system as captured in MEPS. We then classified prescription medications into 2 categories: (1) opioids, which included both "narcotic analgesics" and "narcotic analgesic combinations" (eg, oxycodone/acetaminophen combinations); and (2) nonopioid analgesics, which included nonsteroidal anti-inflammatory drug medications and nonsteroidal anti-inflammatory drug combination medications, and acetaminophen and acetaminophen combination medications. We did not include data on antimigraine medications. Tramadol was classified as an opioid in our study.
Statistical analysis
Analyses were conducted using the survey package of Stata version 14.2 (StataCorp, College Station, TX); a level was set at 0.05. We adjusted for the complex probability survey design of MEPS using sampling weights, stratification, and clustering to provide nationally representative estimates. Our first aim was to determine whether racial and ethnic differences exist in rates of analgesic prescriptions to children in the United States in outpatient health care settings. To address this aim, we first summarized unadjusted weighted rates of analgesic prescribing for children based on racial and ethnic . We then performed multivariate logistic regression analyses, controlling for age, sex, insurance coverage, region of the United States, parent-reported child mental and physical health, total number of outpatient health service visits, and number of medication prescriptions received, to estimate the association between child race and ethnicity and analgesic prescriptions. Separate logistic regression models were conducted for opioid and nonopioid analgesics.
Our secondary aim was to determine the associations between patient-provider race and ethnic concordance and opioid prescription among children in the United States in the outpatient setting. To address this aim, we first examined unadjusted weighted rates of opioid prescription among children based on their providers' race and ethnicity between 2003 and 2014. Bivariate analyses were conducted using x 2 testing for equality of proportions between samples. We then performed multivariate logistic regression analyses to test associations controlling for age, sex, insurance, region, parent-reported child mental and physical health, total number of outpatient health service visits, and number of medication prescriptions received. Separate multivariable logistic regressions were conducted for each of the 3 racial groups of children. In each of the 3 regression analyses, opioid prescription by white providers was held as reference and compared with the child's race-concordant health care provider, with the primary objective of determining whether raceconcordant providers were more likely to prescribe opioids to similar race child participants.
Results
Data from 113,929 children 0 to 17 years of age were available for analysis in the 2003 to 2014 Medical Expenditure Panel Survey database. Sociodemographic and parent-reported physical and mental health status characteristics of child participants are presented in Table 1 . Race and ethnic status of children in the United States has changed between 2003 and 2014. In 2003, 60% of children were white, whereas in 2014, 50% of children were white. The proportion of Hispanic children increased from 2003 to 2014, whereas the proportion of black children remained stable. Rates of opioid and nonopioid analgesic prescribing over time, by each race and ethnic category, are presented in Figure 1 . On average, 2.3% (95% confidence interval [CI], 2.2%-2.5%) of children received an opioid prescription each year. We found higher rates of opioid prescription to white children (annual average 3.0%; 95% CI, 2.7%-3.2%) as compared to black children (annual average 1.7%; 95% CI, 1.5%-2.0%), Hispanic children (annual average 1.4%; 95% CI, 1.2%-1.6%), and Asian children (annual average 0.9%; 95% CI, 0.6%-1.2%). Native American children had similar rates of opioid prescription (2.6%; 95% CI, 1.5%-4.3%) as compared to white children. By contrast, we found higher rates of nonopioid analgesic prescription to minorities: black children (annual average 2.2%; 95% CI, 2.0%-2.5%), Hispanic children (annual average 5.7%; 95% CI, 4.0%-8.0%), Native American children (3.2%; 95% CI, 1.5%-6.6%), and Asian children (annual average 2.0%; 95% CI, 1.5%-2.7%), as compared to white children (annual average 1.3%; 95% CI, 1.2%-1.5%). Data from the multivariate logistic regression examining the association between race and ethnicity and analgesic prescribing for children are presented in Tables 2 and 3 
Opioid prescription by usual source of care provider race and ethnic category
Child and provider race and ethnic concordance for participants who reported having a usual source of care provider is presented in Table 4 . Most white children had race/ethnic concordant relationships with their usual source of care providers (93.5%), whereas 34.3% of black children and 42.7% of Hispanic children had race/ethnic concordant relationships with their health care providers. Among usual source of care providers, white providers were not more likely to prescribe opioids (2.9%) as compared to black (2.2%) and Hispanic (2.2%) providers (P 5 0.06).
Unadjusted rates of opioid prescription to children based on patient and provider race and ethnicity are presented in Figure 2 . We found that minority children who had a race-concordant relationship with their health care providers were no more likely to receive opioids than those with a nonconcordant relationship. In fact, we found that minority children were less likely to receive opioids from minority providers. For example, as shown in the unadjusted rates presented in Figure 2 , black children were less likely to receive opioids from black providers (1.3%) as compared to white providers (2.4%). Similarly, Hispanic children were also less likely to receive opioids from Hispanic providers (1.6%) as compared to white providers (1.7%). Of note, all providers were more likely to provide opioids to white children than black and Hispanic children. Multivariable logistic regression analyses examining associations between opioids and usual source of care provider characteristics, adjusting for covariates, are shown in Table 5 . In the multivariate analysis of black children, we found that black children who had black providers were significantly less likely to receive opioids (AOR 5 0.51; 95% CI, 0.30-0.87) as compared to black children who had white providers. The other 2 analyses involving white and Hispanic children did not reveal differences in opioid prescription attributable to patient-provider concordance.
Discussion
In this nationally representative cross-sectional analysis of outpatient visits of children in the United States, we found significant differences in opioid and nonopioid prescription based on children's race and ethnic status. We found that white children were more likely to receive opioid prescriptions as compared to minority groups, whereas minority children were more likely to receive nonopioid analgesic prescriptions, even after adjusting for important covariates including sociodemographic factors, physical and mental health, and health care use. The only minority group who received similar opioid prescriptions to white children was American Indian/Alaskan Native children.
Our data are consistent with published reports showing racial disparities in opioid prescription during ED visits by children and adolescents in the United States. 15, 17, 22 Goyal et al. and Rasooly et al. found that black children were significantly less likely to receive opioid analgesics compared with white children, and this difference persisted after adjusting for pain severity and other demographic covariates. However, in these studies, black children were more likely to receive nonopioid analgesia than white children. 5, 23 In contrast to ED findings, data from ambulatory surgery settings are inconsistent, with one study from the Pacific Northwest showing differences in opioid use based on race, but a more recent study from the Midwest showing no difference in opioid use by race. 16, 20 However, both of these studies from ambulatory surgery centers were small, regional studies and not nationally representative. Our study is the first, to the best of our knowledge, to document that race and ethnic differences in opioid prescription to children exist in outpatient health care centers.
Potential reasons for differences in opioid prescription can be broadly categorized into those related to the patient and those related to health care providers. Patient-related factors include those related to clinical status and those related to patient preference. Many of the hypothesized patient-related clinical status risk factors related to opioids have not received empirical support. For example, studies have demonstrated that non-white patients present to the ED with the same level of acuity as compared to white patients. 2 Patient preferences regarding analgesia have also been hypothesized to account for racial differences documented in analgesic prescriptions. 13 Recently, a study of adult patients in the ED found no significant difference by race in patients' overall desire for analgesia; 24 however, race and ethnic differences exist for preference of type of analgesia. For example, Hispanic patients are more reluctant to use opioids as compared to white non-Hispanic patients because they are more concerned about risk of addiction, tolerance, and adverse treatment outcomes. 19, 21, 25 On the other hand, Hispanic and black patients are more likely to try OTC medications as compared to white patients. 3, 25 Related, USA families with health care flexible spending accounts may request prescriptions for OTC medications in order to pay for them using pre-tax funds, however the accounts are more common among white families. 8 Thus, race and ethnic-related preference for different types of analgesia could contribute to underlying racial differences in opioid use in outpatient settings. Our findings also support the important role of health care provider factors in opioid differences among children. Some reasons for differences may include provider beliefs and implicit or explicit biases. For example, providers may believe that minorities are not able to obtain opioids because they are less likely to be carried by pharmacies in their areas. 7 Furthermore, health care providers may have biases related to race. Hoffman et al. 12 examined racial bias in pain assessment and treatment recommendations as a basis for disparities in pain treatment for black Americans relative to white Americans. Their primary finding was that white individuals with at least some medical training hold and may use false beliefs about biological differences between black and white patients to inform medical judgments, which may contribute to racial disparities in pain assessment and treatment. Recently, Hollingshead et al. 14 compared race-related stereotypes held by both white and black lay individuals. They found that both white and black laypersons perceived the average white person to be more pain sensitive and more willing to report pain as compared to the average black person. Thus, their conclusion was that both white and black individuals hold similar racial stereotypes concerning pain and its management, which is consistent with previous studies. 4, 26 To better understand the effect of a provider factor in determining opioid disparities, the secondary aim of this study was to determine whether patient-provider race and ethnic concordance was associated with prescription of opioids to children. In contrast to our hypothesis, we did not find that children who have a race-concordant relationship with their health care provider were more likely to receive an opioid prescription as compared to children who were of different race/ethnicity than their provider. In fact, we found that, as a whole, minority children were less likely to receive opioids from minority health care providers. Given that minority persons are more reluctant to use opioids as a whole; our finding may indicate that minority health care providers are more perceptive to their minority patients preferring less opioids as compared to their white patients. On the other hand, white patients may be more likely to request opioids from providers. Thus, our study contributes to understanding of health care provider-related disparities in the United States by finding that race and ethnicity of health care providers may be a strong driver of opioid differences found among children in the United States. These are novel findings that require further investigation to understand why provider racial concordance plays a role in differences related to opioid use.
Results should be considered within the context of several limitations of this study. First, we were unable to determine how many of the opioids prescribed to children actually came from their usual source of care providers because MEPS does not directly link providers to prescriptions. However, it is conceivable that most opioids given to children in outpatient settings would be from familiar providers (as opposed to opioids given after surgery or ED visits). Second, information was not available about children's pain intensity, duration, and interference, or about the patient or parents' desire for analgesia. Inclusion of those specifiers beyond just the presence or absence of a painful condition may have yielded additional information about the context for analgesia use. Third, because this is a secondary cross-sectional analysis of an existing database, we are unable to causally link race, ethnicity, and opioid prescription. Fourth, provider data to determine race and ethnic concordance were only available for a subsample of children and providers.
Associations between race and opioid use were similar in the subsample as compared to the entire sample. Thus, we present data of the entire sample to address the first aim in this article. Fifth, provider race was reported by the patient; thus, there may be some imprecision related to patients' ability to accurately perceive race. Despite these limitations, our study shows that there are significant racial and ethnic differences in opioid prescription during outpatient health care visits among children and adolescents. These differences may be related to biases associated with patient-provider race and ethnic concordance, leading to differential pain management, and contributing to a wide gap in pain management provided to minorities. On the other hand, differences may be related to patient and provider preferences for opioid vs nonopioid medication use. Indeed, white individuals are much more likely to misuse opioids and have increased rates of opioid abuse and poisoning as compared to minorities. 18 This raises questions regarding whether, on a population level, opioids are overprescribed in white individuals or underprescribed in minority individuals. Our study was not designed to answer this fundamental question. However, for individual patients, we want to emphasize that health care providers should guard against inherent racial and ethnic biases and should personalize pain management decisions using best evidence practices. Furthermore, this study provides an important estimation of general analgesic prescribing among children in the United States that may guide future research and clinical service coordination for this vulnerable population.
Our study also has several strengths as compared to other epidemiological studies examining rates of opioid prescription among children and adolescents: (1) we included a very large nationally representative sample spanning 2003 to 2014 rendering multiple years of data available for analysis, and (2) we analyzed prescriptions from the outpatient health care setting, which has not been previously examined in children.
In summary, in a large nationally representative database, we found differences in childhood opioid and nonopioid use based on race and ethnic differences. White children were significantly more likely to receive opioid prescriptions as compared to minorities. We also explored whether patient-provider race and ethnic concordance was associated with opioid prescription. Overall, we found that providers were more likely to prescribe opioids to white children, whereas minority providers were less likely to prescribe opioids to minority children. Based on extant literature, these findings may relate to minority patients' known preference for using less opioid medications. Conversely, white patients may be more likely to request opioid medications for pain control. Future research should focus on understanding differences in preference for opioids based on race and ethnicity in the United States. Table 5 Multivariate logistic regression models examining associations between receipt of opioids and patient-provider race/ethnic concordance. 
